Pulse Therapeutics is proud to announce its merger with ICHOR Vascular and the subsequent creation of Euphrates Vascular. For more information, contact CEO Sean Morris.


Pulse Therapeutics Supports Stroke Awareness Month in May

Stroke is Preventable in 80% of Cases Recognizing Warning Signs, By Adopting Healthy Lifestyle The devastating impact¬†of stroke, the nation’s fourth deadliest disease, is undeniable. Stroke impacts 795,000 people each year, according to the American Heart Association/American Stroke Association (AHA/ASA). It costs patients $33 billion annually and leaves survivors temporarily to permanently paralyzed or otherwise…

Read More